Body composition

Visceral fat: what it is, why it matters, and what reduces it

Visceral fat is stored around internal organs, not under the skin, and carries a higher metabolic risk than subcutaneous fat. DEXA measures it. Training and diet reduce it.

5 min read · by · educational content, not medical advice

What visceral fat is and where it sits

  • Visceral fat is intra-abdominal fat stored around the liver, pancreas, kidneys, and intestines. It is distinct from subcutaneous fat, which sits between the skin and muscle and is visible from the outside.
  • Because visceral fat is metabolically active, it produces inflammatory cytokines and free fatty acids that directly affect insulin sensitivity, liver function, and cardiovascular risk.
  • Two people with identical waist measurements or identical scale weights can have very different amounts of visceral fat — which is part of why DEXA-derived visceral fat area is a more useful clinical data point than waist measurement alone.

Why it matters for health

  • High visceral fat is independently associated with insulin resistance and type 2 diabetes risk, elevated triglycerides and LDL, lower HDL cholesterol, hypertension, and systemic inflammation.
  • The association between visceral fat and cardiometabolic risk is stronger than the association between BMI and those same outcomes. People classified as 'normal weight' can carry metabolically significant amounts of visceral fat.
  • Reducing visceral fat — even without large changes in total bodyweight — produces measurable improvements in metabolic markers.

What actually reduces visceral fat

  • A sustained caloric deficit is the most effective single intervention for reducing visceral fat. The effect is larger and faster than changes in subcutaneous fat.
  • Aerobic training independently reduces visceral fat even in the absence of weight loss — likely through effects on insulin sensitivity and lipolysis in visceral adipose tissue.
  • Resistance training also reduces visceral fat, though the effect size in most studies is somewhat smaller than aerobic training. The combination of resistance training, aerobic activity, and diet produces the largest reductions.
  • GLP-1 receptor agonists (semaglutide, tirzepatide) show consistent and meaningful reductions in visceral fat area in clinical trials, making visceral fat tracking particularly relevant for clients on these medications.

How training and DEXA fit together for visceral fat

  • A baseline DEXA provides a visceral fat area in cm² — a specific, objective number that can be compared across scans.
  • After a 3–6 month structured fat-loss phase (diet plus training), a follow-up scan showing visceral fat reduction is one of the most clinically meaningful changes you can document — more so than scale weight.
  • Realistic expectations: meaningful visceral fat reduction typically requires at least 12–16 weeks of consistent effort. Do not scan too soon after starting.